Abstract:Objectives: The objectives of this study were to screen lactic acid bacteria (LAB) that can produce angiotensin-converting enzyme (ACE) inhibitory peptides and to evaluate their probiotic properties. Methods: Lactic acid bacteria were inoculated into skimmed milk, the proteolysis degree and ACE inhibition rate of fermented milk were determined by colorimetric assays. Two LAB (ZJUIDS09 and ZJUIDS11) that resulted in the highest proteolysis degree and ACE inhibition rate were selected, and their probiotic properties were evaluated, including acid resistance, bile salt resistance, antibiotic resistance, and antibacterial activity. The fermented milk produced by the two strains was treated with simulated gastrointestinal digestive juices, and their ACE inhibition rates were determined. Finally, the two strains were used as starter cultures in the fermentation of Holstein skim milk, Holstein whey, buffalo skim milk and buffalo whey, and the ACE inhibition rates of the fermented milk were determined. Results: The degrees of proteolysis of fermented milk produced by strain ZJUIDS09 and ZJUIDS11 were 5.79%±0.14% and 5.75%±0.10%, respectively. Their ACE inhibition rates were 87.39%±2.44% and 90.41%±0.99%, respectively. And their IC50 were 0.36 and 0.27 mg/mL, respectively. Their ACE inhibition rates after digestion with simulated gastrointestinal juices were decreased to 70.13%±0.15% and 76.39%±2.91%, respectively. Strains ZJUIDS09 and ZJUIDS11 were resistant to acid and bile salt, exhibited antibacterial activity and antibiotic sensitivity, and were identified as Lactobacillus reuteri and Lactobacillus helveticus by 16S rRNA. Comparing Holstein skim milk, Holstein whey, Buffalo skim milk and Buffalo whey after strain fermentation, Holstein skim milk was the most suitable substrates for strains ZJUIDS09 and ZJUIDS11 to produce ACE-inhibitory peptides. Conclusion: Lactobacillus reuteri ZJUIDS09 and Lactobacillus helveticus ZJUIDS11 screened in this study had a strong ability to produce ACE inhibitory peptides and had the potential to develop fermented dairy products with blood pressure-lowering effect.

Characterization of angiotensin-converting enzyme inhibitory activity of fermented milk produced by Lactobacillus helveticus

Angiotensin-Converting Enzyme Inhibitory Activity of Lactobacillus Helveticus Strains from Traditional Fermented Dairy Foods and Antihypertensive Effect of Fermented Milk of Strain H9

Identification and In Silico Analysis of ACE-Inhibitory Peptides Derived from Milk Fermented by Lacticaseibacillus paracasei

Production and Fermentation Characteristics of Angiotensin-I-converting Enzyme Inhibitory Peptides of Goat Milk Fermented by a Novel Wild Lactobacillus Plantarum 69

Novel Angiotensin-Converting Enzyme-Inhibitory Peptides from Fermented Bovine Milk Started by Lactobacillus Helveticus KLDS.31 and Lactobacillus Casei KLDS.105: Purification, Identification, and Interaction Mechanisms

Purification and Identification of Novel Peptides with Inhibitory Effect Against Angiotensin I-Converting Enzyme and Optimization of Process Conditions in Milk Fermented with the Yeast Kluyveromyces Marxianus

Angiotensin-I-converting enzyme inhibitory peptides in milk fermented by indigenous lactic acid bacteria

Separation of Angiotensin-Converting Enzyme Inhibitors from Fermented Milk Prepared with Lactobacillus Casei Hz1

Fermentation characteristics and angiotensin I-converting enzyme-inhibitory activity of Lactobacillus helveticus isolate H9 in cow milk, soy milk, and mare milk.

Screening, Probiotic Properties Evaluation and Application of ACE-inhibitory Peptide-producing Lactic Acid Bacteria

The inhibitory effects of lactobacillus casei 1.2435-fermented milk against Angiotensin-I-converting enzyme

Study on External Conditions of Angiotensin Converting Enzyme Inhibitory Peptide Derived from Fermented Milk

Single and Co-Cultures of Proteolytic Lactic Acid Bacteria in the Manufacture of Fermented Milk with High ACE Inhibitory and Antioxidant Activities

Screening and Identification of Strains of Lactic Acid Bacteria with Angiotensin Converting Enzyme Inhibitory Activity

In vitro antioxidant and angiotensin-converting enzyme inhibitory activity of fermented milk with different culture combinations

Optimization of Fermentation Conditions for the Production of Angiotensin-Converting Enzyme (ACE) Inhibitory Peptides from Cow Milk by Lactobacillus bulgaricus LB6

In-depth peptidomic profile and molecular simulation studies on ACE-inhibitory peptides derived from probiotic fermented milk of different farm animals

Isolation of Angiotensin I-Converting Enzyme Inhibitory Component from Traditional Fermented Mare's Milk

Peptidomics approaches to the discovery and ACE inhibitory effect of casein peptides derived from fermented bovine milk by kefir grains

Optimization of Nutrient Composition for Producing ACE Inhibitory Peptides from Goat Milk Fermented by Lactobacillus bulgaricus LB6

Optimization of Sour Milk Fermentation for the Production of ACE-inhibitory Peptides and Purification of a Novel Peptide from Whey Protein Hydrolysate